Managing epistaxis
Linda Diamond, PA-C
ABSTRACT
An estimated 60% of the population will have a nosebleed
in their lifetime, and 6% will require medical intervention. Uncontrolled nasal bleeding can lead to hypovolemia
and airway compromise. Understanding prevention and
management of epistaxis is especially important to clinicians who manage patients on anticoagulants, supplemental
oxygen therapy, or who have other risk factors for epistaxis.
This article reviews stepwise management for epistaxis and
newer treatment options in adults.
Keywords: epistaxis, nosebleeds, nasal packing, thrombogenic agents, balloon catheter, anticoagulation
Learning objectives
Identify risk factors and causes of epistaxis.
Describe the stepwise management of epistaxis.
List the equipment and medications needed to
manage epistaxis.
can be caused by a variety of factors (Table 1). Anticoagulation, underlying liver disorders, or other blood
coagulopathies can contribute to the inability to control
epistaxis. Recurrent or unilateral epistaxis along with
nasal congestion or nasal obstruction, independent of the
degree of bleeding, may indicate nasal neoplasm.
www.JAAPA.com
Copyright 2014 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
35
CME
Key points
An estimated 60% of the population will have epistaxis at
some time, and 6% will require medical treatment.
Newer options for nasal packing and thrombogenic
materials are less traumatic for patients and healthcare
professionals.
Patients on anticoagulant or antiplatelet medications
should be instructed in nasal care to reduce the risk of
epistaxis.
An epistaxis kit of necessary instruments and supplies may
help healthcare providers treat patients more efficiently
and effectively.
ANATOMY
The nasal cavitytwo chambers divided by the nasal
septumwarms and moistens the air we breathe. The
septum is lined by mucous membrane and contains a
rich vascular supply generating from branches of the
internal and external carotid arteries. More than 90%
of cases of epistaxis occur on the nasal septum in the
vascular area called the Kiesselbach plexus.1 This area
is prone to digital trauma and excessive drying, and is
exacerbated by the use of supplemental oxygen via nasal
cannula. The Kiesselbach plexus is supplied by both the
anterior and posterior ethmoid arteries as well as
branches from the sphenopalatine and greater palatine
arteries (Figure 1). Epistaxis in this area is defi ned
as anterior and is generally self-limiting and easier to
control.
The lateral wall of the nasal cavity is more complex, with
three bony elevations called turbinates or conchae. These
conchae are covered with a thick mucous membrane and
increase the surface area to moisten inhaled air. Posterior
nasal cavity epistaxis occurs in 5% to 10% of nasal bleeding.1 Branches of the internal maxillary artery (sphenopalatine and descending palatine arteries) with a small
contribution from the posterior ethmoid artery make up
the vascular supply to this area. Posterior epistaxis is often
more difficult to visualize and to reach anatomically,
therefore, more difficult to control.1,2
HISTORY AND ASSESSMENT
Obtaining a timeline of the patients nosebleed is important;
the duration of the bleeding may indicate whether the
patient needs more emergent treatment. Refer the patient
to the nearest ED if he or she has had recurrent hard-tocontrol bleeding over several days or a single significant
bleed lasting longer than 1 hour.
Review the patients medical history, looking for
chronic medical conditions that may predispose the
patient to bleeding, such as hypertension, liver disease,
heart disease, or blood disorders. Note and document
if the patient is taking anticoagulants or antiplatelet
36
www.JAAPA.com
TABLE 1.
Causes of epistaxis
Traumatic
Nose picking
Facial injury
Foreign body
Nasogastric tube placements
Barotrauma
Neoplastic
Benign
Malignant
Hematologic
Thrombocytopenia
Hemophilia
Von Willebrand disease
Hereditary hemorrhagic telangiectasia
Hepatic diseases
Anticoagulant or antiplatelet medications
Structural
Dryness
Septal perforation
Surgical procedures
Drug-induced
Nasal sprays
Substance inhalation
Inflammatory
Environmental irritants
Allergic rhinitis
Infections
Copyright 2014 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Managing epistaxis
TABLE 2.
Head lamp
Nasal speculum
Bayonet forceps
Frasier suction #10
Suction setup
Emesis basin
Oxymetazoline
Lidocaine 2% with or without epinephrine
Cotton pledgets or balls/strips
Tongue blades
Eye protection
Nonsterile gloves
Silver nitrate sticks
Antibiotic ointment
Empty 10-mL syringes
Sterile water
Anterior packing (polyvinyl alcohol sponge or lowpressure balloon)
Posterior packing (dual balloon catheter or petroleumimpregnated gauze)
Hemostatic agents of choice
Copyright 2014 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
37
CME
www.JAAPA.com
Copyright 2014 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Managing epistaxis
REFERENCES
1. Viehweg TL, Roberson JB, Hudson JW. Epistaxis: diagnosis and
treatment. J Oral Maxillofac Surg. 2006;64(3):511-518.
2. Pope LE, Hobbs CG. Epistaxis: an update on current management. Postgrad Med J. 2005;81(955):309-314.
3. Choudhury N, Sharp HR, Mir N, Salama NY. Epistaxis and oral
anticoagulant therapy. Rhinology. 2004;42(2):92-97.
4. Kilty SJ, Al-Hajry M, Al-Mutairi D, et al. Prospective clinical
trial of gelatin-thrombin matrix as first line treatment of
posterior epistaxis. Laryngoscope. 2014;124(1):38-42.
5. Mathiasen RA, Cruz RM. Prospective, randomized, controlled
clinical trial of a novel matrix hemostatic sealant in patients with
acute anterior epistaxis. Laryngoscope. 2005;115(5):899-902.
6. Jacobs JR, Levine LA, Davis H, et al. Posterior packs and the
nasopulmonary reflex. Laryngoscope. 1981;91(2):279-284.
7. Vitek J. Idiopathic intractable epistaxis: endovascular therapy.
Radiology. 1991;181(1):113-116.
8. Herkner H, Havel C, Mllner M, et al. Active epistaxis at ED
presentation is associated with arterial hypertension. Am J
Emerg Med. 2002;20(2):92-95.
9. Herkner H, Laggner AN, Mllner M, et al. Hypertension in
patients presenting with epistaxis. Ann Emerg Med. 2000;35(2):
126-130.
10. Thong JF, Lo S, Houghton R, Moore-Gillon V. A prospective
comparative study to examine the effects of oral diazepam on
blood pressure and anxiety levels in patients with acute
epistaxis. J Laryngol Otol. 2007;121(2):124-129.
www.JAAPA.com
Copyright 2014 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
39